Meeta Chatterjee is a director of Editas Medicine Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Werewolf Therapeutics, Inc.
24 May 24
4
Werewolf Therapeutics, Inc.
23 Jun 23
4
Editas Medicine, Inc.
5 Jun 23
4
Editas Medicine, Inc.
13 Jun 22
4
Werewolf Therapeutics, Inc.
3 Jun 22
4
Werewolf Therapeutics, Inc.
1 Nov 21
3
Werewolf Therapeutics, Inc.
1 Nov 21
4
Editas Medicine, Inc.
7 Jun 21
4
Editas Medicine, Inc.
18 Dec 20
3
Editas Medicine, Inc.
18 Dec 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
24 May 24 | HOWL Werewolf Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 4.88 | 17,500 | 85.40 k | 17,500 |
21 Jun 23 | HOWL Werewolf Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.81 | 13,200 | 37.09 k | 13,200 |
1 Jun 23 | EDIT Editas Medicine | Stock Option Common Stock | Grant | Acquire A | No | No | 9.55 | 25,000 | 238.75 k | 25,000 |